William (Billy) Hutchens focuses his practice on mergers and acquisitions, and general corporate matters. He represents domestic and international financial and strategic buyers, sellers and investors in connection with public and private mergers, acquisitions, divestitures, joint ventures, venture capital and other private equity investments, corporate restructurings, recapitalizations, and similar transactions. Billy also regularly advises on a variety of general corporate matters, including organizational matters, corporate governance, equity incentive matters and commercial contracts.
Represented Neurovance, a venture-funded company focused on developing a novel ADHD therapy, in its sale to Otsuka Pharmaceutical pursuant to which Otsuka paid US$100 million up front, plus additional contingent consideration payable upon achievement of post-closing milestones
Represented H.I.G. Capital, LLC, a Miami, Florida-based private equity firm, in multiple add-on acquisitions for its portfolio company Harrison Gypsum, LLC (d/b/a ACG Materials), a national provider of rock, minerals and related products, including the acquisitions of Pinnacle Materials, LLC’s Eagle Ford Division, The Gravel Company, LLC, J.A. Jack & Sons, Inc., and Art Wilson Co.
Represented Peak Rock Capital, LLC, an Austin, Texas-based private equity firm, in multiple platform and add-on acquisitions, including the acquisitions of Atlas Paper Mills, LLC, Accurate Paper Recycling, Inc., Roses Southeast Papers, LLC, Hunter’s Specialties, Inc., and Buck Bomb, Inc.
Represented Moelis Capital Partners, LLC, a New York-based private equity firm, in its acquisition of OmniSYS, LLC, a market leader in processing medical claims and providing compliance services for retail and mail order pharmacies
Represented The HEICO Companies, LLC, a diversified holding company, in its acquisition of Kinedyne Corporation, a leading manufacturer and distributor of cargo control products, as well as Kinedyne Corporation’s Canadian, Mexican and Chinese affiliates and subsidiaries
Represented Baxter International, Inc. (NYSE: BAX), a global leader in medical devices and bioscience products, in its acquisition of Chatham Therapeutics, LLC, a clinical development-stage biotechnology company, for an upfront payment of $70 million, plus additional contingent consideration payable upon achievement of certain milestones
Represented Mitsui & Co. (USA), Inc., a US subsidiary of the diversified Japanese general trading company Mitsui & Co., Ltd. (TYO: 8031), in its investment in Sanderling Renal Services, a provider of dialysis and renal services
Represented Kingsway Financial Services, Inc. (NYSE: KFS), a holding company with subsidiaries primarily engaged in the property and casualty insurance business, in the sale of Assigned Risk Solutions, Ltd. to National General Holdings Corp. (NASDAQ: NGHC) for $47 million
Represented Duvel Moortgat NV, a family-controlled Belgian brewery founded in 1871, in its investment in Firestone Walker Brewing Company, a Paso Robles, California-based craft beer company
Represented Panduit Corp., a global leader in unified physical infrastructure-based solutions, in its acquisition of SynapSense Corporation, a leading provider of wireless data center monitoring and cooling control solutions
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.